RA CAPITAL MANAGEMENT, L.P. - Former 10% Owner at iTeos Therapeutics, Inc.

Issuer-level insider activity

Role
Former 10% Owner
Issuer ticker
ITOS
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by RA CAPITAL MANAGEMENT, L.P. since 14 Sep 2025

Reported holdings for RA CAPITAL MANAGEMENT, L.P. in iTeos Therapeutics, Inc.

Form 4 holding Former 10% Owner

iTeos Therapeutics, Inc.

Security class
Pre- Funded Warrants (Right to Buy)
Shares / value
6,614,285
Estimated value
$115,743,373
Report date
12 May 2024
Price
$17.50
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Former 10% Owner

iTeos Therapeutics, Inc.

Security class
Common Stock
Shares / value
2,545,510
Estimated value
$21,305,919
Report date
12 May 2024
Price
$8.37
Ownership
Indirect

Transaction history for RA CAPITAL MANAGEMENT, L.P. in iTeos Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .